Part B carriers all over the map on bone density studies

Why This Topic Matters

Bone density testing is commonly performed in outpatient and women’s health settings, but payment depends on both national Medicare requirements and local carrier policy. Understanding the scope of the article helps readers determine whether they need guidance on coverage policy, coding by test method, and component billing considerations.

Article Sections

1. Medicare coverage background

   Introduces Medicare’s general approach to bone density screening studies and the factors that affect payment. Summarizes the overall context for Part B coverage decisions.

2. Bone density study methods and clinical use

   Describes the types of bone density technologies mentioned in the article and the general body sites that may be measured. Also notes the clinical context in which these studies are commonly used.

3. Coverage criteria and risk categories

   Outlines the broad patient categories discussed for Medicare coverage and the national timing limitations referenced in the article. Focuses on the policy framework rather than specific coding instructions.

4. Procedure codes for bone density studies

   Lists the procedure code families used to report the different study methods described in the article. This section helps identify which reporting options are discussed for the various technologies.

5. ICD-9 diagnosis code policy variation by carrier

   Explains that local Medicare carriers maintain their own approved diagnosis code sets for these studies. Discusses the variability of local policy across states and carriers.

6. Professional and technical component billing

   Addresses how the service may be divided between professional and technical components and how billing may differ depending on where the study is performed. Also notes the article’s discussion of component-based reimbursement.